Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsSolid TumorsProtocol groupAggressive LymphomasNeuro-OncologyTransplantationDiseaseMalignant MeningitisNHL, CNS-NHLSubgroupLymphomatous MeningitisICD10C79.3C83.3MeSHCentral Nervous System NeoplasmsLymphoma, Non-HodgkinMeningeal CarcinomatosisSequenceFreiburg CNS-NHL StudyMATRIXMTRX8000/RITU375/TMZL150, CNS lymphoma, C1 (PID1859) -|- C2 (PID1860) -|- C3 (PID1861) -|- C4 (PID1864) -|- C5 (PID1865) -|- C6 (PID1866)R-MP (RITU375/MTRX3000/PRCR60), CNS Lymphoma, C1 (PID1191) -|- C2-3 (PID1030) -|- PRCR100, maint. (PID1031)RITU375/MTRX3500/PRCR100/VNCR2, CNS lymphoma, C1-3 (PID1896) -|- RITU375/CYTA3000, C4-6 (PID1901)RITU750/TMZL150, CNS-NHL, ind. (PID2437) -|- TMZL150, cons. (PID2438) -|- MTPR1, maint. (PID2439)ChemotherapyChemo-substanceCarboplatinCarmustineCytarabineDexamethasoneEtoposideIfosfamideMethotrexateMethylprednisoloneProcarbazineRituximabTemozolomideThiotepaVincristineChemo-substanceCarboplatinCarmustineCytarabineDexamethasoneEtoposideIfosfamideMethotrexateMethylprednisoloneProcarbazineRituximabTemozolomideThiotepaVincristineChemo-substanceCarboplatinCarmustineCytarabineDexamethasoneEtoposideIfosfamideMethotrexateMethylprednisoloneProcarbazineRituximabTemozolomideThiotepaVincristineChemo-substanceCarboplatinCarmustineCytarabineDexamethasoneEtoposideIfosfamideMethotrexateMethylprednisoloneProcarbazineRituximabTemozolomideThiotepaVincristineNo. Substances12345 RadiotherapySupportive therapySupportive substanceAciclovirAmphotericin BAprepitantBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneDextrose 5%DimetindenFilgrastimFluconazoleFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPosaconazolePotassium chloridePrednisoloneSodium BicarbonateSupportive substanceAciclovirAmphotericin BAprepitantBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneDextrose 5%DimetindenFilgrastimFluconazoleFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPosaconazolePotassium chloridePrednisoloneSodium BicarbonateSupportive substanceAciclovirAmphotericin BAprepitantBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneDextrose 5%DimetindenFilgrastimFluconazoleFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPosaconazolePotassium chloridePrednisoloneSodium BicarbonateSupportive substanceAciclovirAmphotericin BAprepitantBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneDextrose 5%DimetindenFilgrastimFluconazoleFolinic acidFosaprepitantFurosemideGranisetronMesnaNaCl 0.9%ParacetamolPegfilgrastimPosaconazolePotassium chloridePrednisoloneSodium BicarbonateNo. Substances156789111213141516Protocol classificationTherapy classificationalternativecurrent standardstudy analogIntensityhigh doseStandard doseTherapy indicationFirst lineSecond lineTherapy phaseautologous stem cell transplantationconditioningConsolidationInductionMaintenanceTherapy intentioncurativedisease controlpalliativeRisksAnemia Hb below 8g/dlCardiotoxicityDiarrheaEmetogenicityEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)FatigueFebrile NeutropeniaHepatotoxicityHyperglycemiaHypokalemiaHyponatremiaIncrease AminotransferasesInfectionsLeukopeniaLymphopeniaMucositisNephrotoxicityNeuropathyNeutropeniaPneumonitisPyrexiaRashRenal FailureThrombocytopenia below 50 000/µlThromboembolic Event only studiesPublicationAuthorFerreri AJFritsch KHouillier CIllerhaus GNayak LRubenstein JLDiseaseErstdiagnose eines primären NHL des ZNS, 18-65 Jahreneudiagnostiziertes primäres ZNS-Lymphom, > 60 JahreNeu diagnostiziertes primäres ZNS-Lymphom, > 66 Jahre, Karnofsky > 70neudiagnostiziertes primäres ZNS-Lymphom, > 66 Jahre, Karnofsky > 70neudiagnostiziertes primäres ZNS-Lymphom, ECOG 0-2Neudiagnostiziertes primäres ZNS-Lymphom, ECOG 0-2primäres ZNS-Lymphom, Rezidivtherapie, Karnofsky Status größer 60%primäres ZNS-NHL, ErstdiagnoseZentrales B-NHL, Erstlinie, ECOG 0-3OriginAlbert-Ludwigs University, Freiburg, Germany, Freiburger ZNS-NHL ProtokollDepartment of Haematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Primain StudyDepartment of Neurology, Memorial Sloan-Kettering Cancer Center, New York, USA, North American Brain Tumor ConsortiumHelen Diller Comprehensive Cancer Center, University of California, San Francisco, CALGB 50202 (Alliance 50202)IRCCS San Raffaele Scientific Institute, Milan, Italy, IELSG32 trialMATRix / IELSG43 StudieUniversites Paris, Paris, France, LOC network studyProtocols in Revision 23 protocols foundProtocols under revision.Carmustine 400 / Thiotepa 5, consolidation before autologous Stem Cell Transplantation, CNS- Non-Hodgkin Lymphoma (PID890)Cytarabine 2000 / Etoposide 5, CNS Lymphoma, cycle 6 (PID1866)Methotrexate 500/3000, Malignant Meningitis (PID1000)Methotrexate 8000 / Rituximab 375 / Temozolomide 150, CNS Lymphoma, cycle 1 (PID1859)Methotrexate 8000 / Rituximab 375 / Temozolomide 150, CNS Lymphoma, cycle 2 (PID1860)Methotrexate 8000 / Temozolomide 150, CNS Lymphoma, cycle 3 (PID1861)Methotrexate 8000 / Temozolomide 150, CNS Lymphoma, cycle 4 (PID1864)Methotrexate 8000 / Temozolomide 150, CNS Lymphoma, cycle 5 (PID1865)Methylprednisolone 1000, CNS Lymphoma, maintenance. (PID2439)Rituximab 375 / Carboplatin 300 / Ifosfamide 1.5 / Etoposide 100 / Dexamethasone 40, CNS- Non-Hodgkin Lymphoma, consolidation (PID831)Rituximab 375 / Carmustine 400 / Thiotepa 5, CNS- Non-Hodgkin Lymphoma, conditioning, cycle 5 (PID1883)Rituximab 375 / Cytarabine 3000 / Thiotepa 40, CNS- Non-Hodgkin Lymphoma, induction, cycle 3 (PID1881)Rituximab 375 / Cytarabine 3000 / Thiotepa 40, CNS- Non-Hodgkin Lymphoma, Induction, Cycle 4 (PID1882)Rituximab 375 / Cytarabine 3000, CNS- lymphoma, cycle 4-6 (PID1901)Rituximab 375 / Methotrexate 3000 / Procarbazine 60 - Procarbazine 100, maintenance, CNS- Lymphoma (PID1031)Rituximab 375 / Methotrexate 3000 / Procarbazine 60, CNS lymphoma, cycle 1 (PID1191)Rituximab 375 / Methotrexate 3000 / Procarbazine 60, CNS- lymphoma, cycle 2-3 (PID1030)Rituximab 375 / Methotrexate 3500 / Procarbazine 100 / Vincristine 2, CNS Lymphoma, cycle 1-3 (PID1896)Rituximab 375 / Methotrexate 500/3000 / Cytarabine 2000 / Thiotepa 30, CNS- Non-Hodgkin Lymphoma, induction (PID703)Rituximab 375 / Methotrexate 8000, CNS- Non-Hodgkin Lymphoma, induction, cycle 1 (PID1879)Rituximab 375 / Methotrexate 8000, CNS- Non-Hodgkin Lymphoma, induction, cycle 2 (PID1880)Rituximab 750 / Temozolomide 150, CNS Lymphoma, Induction (PID2437)Temozolomide 150, CNS Lymphoma, consolidation (PID2438)